- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01391767
Histologic Evaluation of Healing Following Tooth Extraction With Ridge Preservation Using NuOss XC and NuOss Particulate
Study Overview
Detailed Description
Patients presenting to the University of Oklahoma College of Dentistry Graduate Periodontics Clinic who are treatment planned for tooth extraction and placement of dental implant(s) will be interviewed for possible participation in the study. Forty extraction sites will be included in this study to provide statistical significance.
The ridge preservation sites, using either NuOss XC or NuOss particulate, will be selected randomly. The first site will be selected using the flip of a coin. Thereafter, every other site will be grafted using NuOs XC. The ridge preservation procedure will involve tooth extraction with as little trauma as possible to preserve all four bony socket walls, curettage of the socket to remove all periodontal ligament fibers and granulation tissue, placement of the graft material into the socket and coverings the graft material with long-lasting collagen membrane. Facial and lingual mucoperiosteal flaps will be elevated to facilitate securing of the membrane with long-lasting absorbable sutures. Patient will be given prescriptions for analgesics and antibiotics as necessary.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73126
- University of Oklahoma College of Dentistry
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
INCLUSION CRITERIA:
- may be either male or female
- must be between 18 and 64 years old
- must be of sufficiently good health to undergo routine dental treatment, including the surgical procedures associated with tooth extraction and placement of NuOss XC or NuOss particulate
- must agree to remain in study for 6 months after ridge preservation (grafting)
- must be able to physically, emotionally, and financially undergo the surgical and restorative (implant replacement) procedures planned.
- must not have medical conditions that preclude the removal of indicated teeth and placement of NuOss XC or NuOss particulate
- must have at least one single-rooted tooth to be extracted
- must consent to tooth extractions, socket augmentation and implant placement
- Patients with or without dental insurance
Exclusion Criteria:
- have any requirements for antibiotic premedication for heart murmurs, artificial joints, or any other condition
- have a history of significant heart, stomach, liver, kidney, blood, immune system or other organ impairment or systemic disease that would prevent their undergoing the proposed treatment
- smoke ≥ 10 cigarettes per day or use other tobacco products
- have a religious or philosophical aversion to having processed bovine bone or collagen used in their mouth
- have taken any investigational drugs anytime in the previous month
- have dental conditions likely to require treatment, necessitating exit from the study such as deep caries, abscesses, or moderate-severe periodontal disease(s).
- have sockets that do not have four bony walls intact.
- cannot comply with treatment and follow-up visits for 6 months
- have had significant radiation exposure (occupational, therapeutic, diagnostic).
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
NuOss XC
Bone grafting material used in this group will be NuOss XC.
|
NuOss XC is a bone grafting material that will be placed in extraction socket site.
|
NuOss Particulate
Bone grafting material used in this group will be NuOss Particulate.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Histological analysis: All sections removed from the osteotomy (hole where implant will be placed) at time of implant placement to be evaluated by a single evaluator, using a semi-quantitative scoring system
Time Frame: 12-18 months
|
Histological processing: Specimens to be trimmed and embedded in methyl methacrylate (MMA). One hematoxylin and eosin (H&E) stained section, and one Goldner's trichrome-stained section to be taken from each block in a longitudinal plane through the approximate center of each defect. Goldner's trichrome-stained slides to be scored for the presence of bone and bone marrow as a percent of the total defect area. H&E-stained slides to be used to evaluate residual collagen and residual bone mineral as a percent of the total defect area. |
12-18 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Robert Carson, DMD, MS, University of Oklahoma College of Dentistry
Publications and helpful links
General Publications
- Iasella JM, Greenwell H, Miller RL, Hill M, Drisko C, Bohra AA, Scheetz JP. Ridge preservation with freeze-dried bone allograft and a collagen membrane compared to extraction alone for implant site development: a clinical and histologic study in humans. J Periodontol. 2003 Jul;74(7):990-9. doi: 10.1902/jop.2003.74.7.990.
- Jemt T, Lekholm U. Implant treatment in edentulous maxillae: a 5-year follow-up report on patients with different degrees of jaw resorption. Int J Oral Maxillofac Implants. 1995 May-Jun;10(3):303-11.
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Nuoss-15852
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Oral Ridge Preservation
-
Cairo UniversityNot yet recruitingSocket Preservation, Alveolar Ridge Deficiency, Alveolar Ridge Preservation
-
University of Alabama at BirminghamActive, not recruiting
-
University of Maryland, BaltimoreCompleted
-
University of LouisvilleCompletedRidge PreservationUnited States
-
Yasmine FouadCompletedAlveolar Ridge Preservation
-
Mimetis Biomaterials S.L.Active, not recruitingAlveolar Ridge PreservationChile, Spain
-
University of California, San FranciscoCompletedAlveolar Ridge Preservation
-
Cairo UniversityNot yet recruitingAlveolar Ridge PreservationEgypt
-
Hams Hamed AbdelrahmanActive, not recruiting
-
Orton Orthopaedic HospitalTampere University; Biomendex Oy; Oral Hammaslääkärit Oy, Qmedical Pikku HuopalahtiTerminated
Clinical Trials on NuOss XC
-
Kenneth BeerAllerganUnknownMandibular HypoplasiaUnited States
-
University of BarcelonaCompletedQuality of Life | SatisfactionSpain
-
AllerganCompletedMid-facial Volume Deficit Related to AgingUnited States, Canada
-
Össur EhfMethodist Rehabilitation Center; Baker Orthotics & Prosthetics; Virginia Prosthetics...CompletedAmputation | Prosthesis UserUnited States
-
AllerganCompletedSkin Smoothness of the CheeksUnited States, Puerto Rico
-
AllerganCompletedChin RetrusionUnited States
-
AllerganCompletedModerate to Severe Nasolabial FoldsUnited States
-
Baumann Cosmetic and Research InstituteCompleted
-
AllerganCompletedTemple HollowingUnited States, Puerto Rico
-
Dongkook Pharmaceutical Co., Ltd.CompletedNasolabial FoldsKorea, Republic of